1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,000 | 0,001 | 04.01. |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 23.12.25 | Peptonic Medical AB. Corporate reconstruction formally concluded following dismissal decision | 1 | Cision News | ||
| 23.12.25 | Peptonic Medical AB's Reconstruction plan becomes legally binding and the reconstruction is concluded | 1 | Cision News | ||
| 16.12.25 | Peptonic Medical AB clarifies expected conclusion of its corporate reconstruction | 2 | Cision News | ||
| 28.11.25 | Peptonic Medical AB's reconstruction plan approved by the Uppsala District Court | 1 | Cision News | ||
| 27.11.25 | Peptonic Medical AB: Plan Hearing Held at Uppsala District Court | 1 | Cision News | ||
| PEPTONIC MEDICAL Aktie jetzt für 0€ handeln | |||||
| 27.11.25 | Peptonic Medical AB Presents Current Sales Figures | 1 | Cision News | ||
| 17.11.25 | Peptonic Medical AB (publ) - Corporate Restructuring Continues | 1 | Cision News | ||
| 30.10.25 | PEPTONIC MEDICAL AB: Peptonic Medical receives part of first order from Joylux worth USD 126,000 | 2 | Cision News | ||
| 27.10.25 | Date for the Plan Meeting in the Corporate Reorganization of Peptonic Medical AB (publ) Announced | 1 | Cision News | ||
| 23.10.25 | Reconstruction Plan in Peptonic Medical AB (publ)'s Corporate Restructuring Published | 2 | Cision News | ||
| 14.10.25 | PEPTONIC MEDICAL AB: Peptonic Medical signs strategic distribution agreement with Joylux Inc. for the USA, Canada, Mexico, and the UK | 2 | Cision News | ||
| 19.09.25 | PEPTONIC MEDICAL AB: Peptonic Medical: Uppsala District Court approves extension of corporate reconstruction | 2 | Cision News | ||
| 10.09.25 | PEPTONIC MEDICAL AB: Peptonic Medical requests extension of corporate reconstruction and provides update on financial performance | 1 | Cision News | ||
| 26.08.25 | Peptonic Medical AB: Anna Linton resigns as CEO | 2 | Cision News | ||
| 07.01.25 | XFRA CAPITAL ADJUSTMENT INFORMATION - 07.01.2025 | 489 | Xetra Newsboard | Das Instrument 0HC0 CA6083842022 MOJAVE BRANDS INC. EQUITY wird cum Kapitalmassnahme gehandelt am 07.01.2025 und ex Kapitalmassnahme am 08.01.2025 The instrument 0HC0 CA6083842022 MOJAVE BRANDS INC.... ► Artikel lesen |
15 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SIEMENS HEALTHINEERS | 44,140 | -1,74 % | JEFFERIES stuft Siemens Healthineers auf 'Buy' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat die Einstufung für Siemens Healthineers vor Zahlen zum ersten Geschäftsquartal auf "Buy" mit einem Kursziel von 60 Euro belassen. Der Medizintechnikkonzern... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 40,170 | -1,45 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| FRESENIUS | 47,730 | -2,55 % | Amneal Pharma, MAbxience: FDA Approves Denosumab Biosimilars Referencing Amgen's Prolia And XGEVA | THOUSAND OAKS (dpa-AFX) - Amneal Pharmaceuticals, Inc. (AMRX) announced late Monday that the U.S. Food and Drug Administration has approved the Biologics Licensing Applications or BLAs for Boncresa... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 38,400 | +2,54 % | S&P Dow Jones Indices: BrightSpring Health Services Set to Join S&P SmallCap 600 | NEW YORK, Oct. 14, 2025 /PRNewswire/ -- BrightSpring Health Services Inc. (NASD: BTSG) will replace Veritex Holdings Inc. (NASD: VBTX) in the S&P SmallCap 600 effective... ► Artikel lesen | |
| GENEDX | 132,30 | +1,72 % | GeneDx to Participate in Upcoming Investor Conferences | GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced that company management will participate in upcoming investor conferences:
Stifel... ► Artikel lesen | |
| PROGYNY | 25,740 | +0,23 % | Progyny, Inc. Announces Third Quarter 2025 Results | Reports Revenue of $313.3 Million, Reflecting 9.3% GrowthRaises Full Year Guidance to Reflect Continued Strength in Member EngagementSelling Season Yields Over 80 New Clients, 900,000 New Lives, and... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 20,225 | +2,41 % | Alignment Healthcare Reports Third Quarter 2025 Results, Surpasses High-End of Guidance Across All Key Metrics | Reports Q3 revenue of $993.7 million, up 43.5% year-over-yearBeats high end of third quarter guidance and raises full-year outlook across all key metrics: membership, revenue, adjusted gross profit... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 30,760 | -2,22 % | PROCEPT BioRobotics Reports Third Quarter 2025 Financial Results and Issues 2026 Revenue Guidance | SAN JOSE, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| BETA BIONICS | 29,250 | -4,00 % | Beta Bionics, Inc.: Beta Bionics Reports Third Quarter 2025 Financial Results and Raises Full Year 2025 Guidance | IRVINE, Calif., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 39,620 | -0,95 % | Carl Zeiss Meditec: JETZT LESEN! | ||
| ADAPTHEALTH | 9,670 | -2,81 % | AdaptHealth: Strategische Expansion und Technologie-Investitionen als Wachstumstreiber | ||
| PRIVIA HEALTH GROUP | 23,460 | -1,05 % | Privia Health Group, Inc.: Privia Health Reports Third Quarter 2025 Financial Results | Very Strong Third Quarter and Year-to-Date Performance Across the BusinessNet Income +94.1% and Adjusted EBITDA +61.6% compared to 3Q'24Implemented Providers +13.1% and Practice Collections +27.1%... ► Artikel lesen | |
| HEARTFLOW | 29,040 | -0,38 % | Heartflow, Inc.: Heartflow FFRCT Analysis Delivers Prognostic Power and Significant Cost Savings in New Analyses of Over 90,000 Patients with Coronary Artery Disease | Lesion-specific FFRCT predicts individual cardiovascular outcomes and delivers greater-than-modeled cost savings for real-world population in FISH&CHIPS analyses from England's National Health ServiceMOUNTAIN... ► Artikel lesen | |
| BILLIONTOONE | 89,29 | +9,10 % | BillionToOne, Inc.: BillionToOne Reports Third Quarter 2025 Results | MENLO PARK, Calif., Dec. 09, 2025 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are... ► Artikel lesen | |
| AVEANNA HEALTHCARE | 8,090 | -0,98 % | Aveanna Healthcare Holdings, Inc: Aveanna Healthcare Holdings Announces Third Quarter Financial Results and Revised 2025 Outlook | Third Quarter Revenue was $621.9 million, a 22.2% increase over the prior year periodThird Quarter Net income was $14.1 million compared to Net loss of $42.8 million for the prior year periodAdjusted... ► Artikel lesen |
PEPTONIC MEDICAL AB gehört der Branche Gesundheitswesen an. Der aktuelle Kurs liegt bei 0,000 Euro und damit 0,00 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu PEPTONIC MEDICAL AB finden Sie auf Wallstreet Online.